Europe Acute Respiratory Distress Syndrome (ARDS) Treatment Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	188 Pages	Data Bridge Market Research	October, 2023	DAABD18360465

Best Price Guarantee
Price	from $3,500
Length	188 Pages
Publisher	Data Bridge Market Research
Published Date	October, 2023
SKU	DAABD18360465

Europe Acute Respiratory Distress Syndrome (ARDS) Treatment Market

The Europe acute respiratory distress syndrome (ARDS) treatment market is expected to reach USD 2,764,971.40 thousand by 2030, from USD 1,356,879.02 thousand in 2022, growing at the CAGR of 9.7% in the forecast period of 2023 to 2030.
Market Segmentation
Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type (Mechanical Ventilation, Corticosteroids, Antiviral Medication, Extracorporeal Membrane Oxygenation (ECMO), Tocilizumab, and Others), Cause ( Sepsis, Inhalation of Harmful Substances, Severe Pneumonia, and Others), Route of Administration (Parenteral, Oral, and Others), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Country (Germany, France, U.K., Italy, Spain, Turkey, Hungary, Netherlands, Switzerland, Austria Lithuania, Poland, Russia, Ireland, Norway, and rest of Europe) - Industry Trends and Forecast to 2030.

Overview of Europe Acute Respiratory Distress Syndrome (ARDS) Treatment Market Dynamics

Driver
• Increasing prevalence and incidence of acute lung injury in the market

Restraint

• High cost of device and treatment

Opportunity

• Strategic initiatives joined with new product launches by market players
Market Players

Some of the major market players operating in the Europe Acute Respiratory Distress Syndrome (ARDS) market are listed below:

• Gilead Sciences, Inc.
• Terumo Medical Corporation
• Getinge AB.
• LivaNova PLC
• Medtronic
• ResMed
• Fisher & Paykel Healthcare Limited.
• Drägerwerk AG & Co. KGaA
• NIPRO
• Fresenius SE & Co. KGaA
• Hamilton Medical
• Pfizer Inc.
• WEINMANN Emergency Medical Technology GmbH + Co. KG
• EUROSETS
• Armstrong Medical
• nice Neotech Medical Systems Pvt. Ltd.
• Besmed Health Business Corp.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Europe Acute Respiratory Distress Syndrome (Ards) Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market End User Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter’s Five Forces; 4.3 Insurance Reimbursement; 4.3.1 Center For Medicare Services (Cms)–elso (Extracorporeal Life Support Organization); 4.3.2 Health Resources And Services Administration; 4.3.3 Abbott Coding Guide For Ecmo; 4.3.4 Central Government Health Scheme (Cghs); 4.3.5 Cern Health Insurance Scheme; 4.3.6 American Society Of Clinical Oncology (Asco) – (Medicare & Medicaid); 4.3.7 American Hospital Association; 4.4 Pipeline Analysis; 4.5 Pricing Analysis
5 Market Overview: 5.1 Drivers; 5.1.1 Increasing Prevalence And Incidence Of Acute Lung Injury; 5.1.2 Wide Range Of Risk Factors For Ards Treatment; 5.1.3 Rising Rate Of Air Pollution And Unhealthy Lifestyle; 5.1.4 Increasing Accident Rates And Trauma Causing Ards; 5.2 Restraints; 5.2.1 Complications Associated With The Treatment; 5.2.2 High Cost Of Devices And Treatment; 5.3 Opportunities; 5.3.1 Rising Healthcare Expenditure To Improve Treatment Facilities; 5.3.2 Strategic Initiatives Joined With New Product Launch By Market Players; 5.3.3 Improving Awareness Regarding Ard Syndrome; 5.4 Challenges; 5.4.1 Stringent Rules & Regulations; 5.4.2 Multiple Challenges Faced By Icu Staff
6 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type: 6.1 Overview; 6.2 Mechanical Ventilation; 6.2.1 High-flow Nasal O2; 6.2.2 Bi-level Positive Airway Pressure; 6.2.3 Continuous Positive Airway Pressure; 6.2.4 Prone Position Ventilation; 6.2.5 Others; 6.3 Corticosteroids; 6.3.1 Methylprednisolone; 6.3.2 Dexamethasone; 6.3.3 Others; 6.4 Antiviral Medication; 6.4.1 Ribavirin; 6.4.2 Oseltamivir; 6.4.3 Others; 6.5 Extracorporeal Membrane Oxygenation (Ecmo); 6.6 Tocilizumab; 6.7 Others 7 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause; 7.1 Overview; 7.2 Sepsis; 7.3 Inhalation Of Harmful Substances; 7.4 Severe Pneumonia; 7.5 Others
8 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration: 8.1 Overview; 8.2 Parenteral; 8.2.1 Intravenous; 8.2.2 Intramuscular; 8.3 Oral; 8.4 Others
9 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User: 9.1 Overview; 9.2 Hospitals; 9.3 Specialty Clinics; 9.4 Home Healthcare; 9.5 Others
10 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel: 10.1 Overview; 10.2 Direct Tender; 10.3 Hospital Pharmacy; 10.4 Retail Pharmacy; 10.5 Online Pharmacy 11 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region; 11.1 Europe; 11.1.1 Germany; 11.1.2 France; 11.1.3 U.K.; 11.1.4 Italy; 11.1.5 Spain; 11.1.6 Turkey; 11.1.7 Netherlands; 11.1.8 Switzerland; 11.1.9 Belgium; 11.1.10 Russia; 11.1.11 Rest Of Europe
12 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, Company Landscape: 12.1 Company Share Analysis: Europe
13 Swot Analysis
14 Europe Acute Respiratory Distress Syndrome (Ards) Treatment, Cps: 14.1 Gilead Sciences Inc.; 14.1.1 Company Snapshot; 14.1.2 Revenue Analysis; 14.1.3 Company Share Analysis; 14.1.4 Product Portfolio; 14.1.5 Recent Development; 14.2 Terumo Corporation; 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Company Share Analysis; 14.2.4 Product Portfolio; 14.2.5 Recent Development; 14.3 Getinge; 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Company Share Analysis; 14.3.4 Product Portfolio; 14.3.5 Recent Development; 14.4 Livanova Plc; 14.4.1 Company Snapshot; 14.4.2 Revenue Analysis; 14.4.3 Company Share Analysis; 14.4.4 Product Portfolio; 14.4.5 Recent Developments; 14.5 Medtronic; 14.5.1 Company Snapshot; 14.5.2 Revenue Analysis; 14.5.3 Company Share Analysis; 14.5.4 Product Portfolio; 14.5.5 Recent Developments; 14.6 Armstrong Medical; 14.6.1 Company Snapshot; 14.6.2 Product Portfolio; 14.6.3 Recent Development; 14.7 Besmed Health Business Corp.; 14.7.1 Company Snapshot; 14.7.2 Product Portfolio; 14.7.3 Recent Developments; 14.8 Drägerwerk Ag & Co. Kgaa; 14.8.1 Company Snapshot; 14.8.2 Revenue Analysis; 14.8.3 Product Portfolio; 14.8.4 Recent Developments; 14.9 Eurosets; 14.9.1 Company Snapshot; 14.9.2 Product Portfolio; 14.9.3 Recent Development; 14.10 Fisher & Paykel Healthcare Limited; 14.10.1 Company Snapshot; 14.10.2 Revenue Analysis; 14.10.3 Product Portfolio; 14.10.4 Recent Developments; 14.11 Fresenius Se & Co. Kgaa.; 14.11.1 Company Snapshot; 14.11.2 Revenue Analysis; 14.11.3 Product Portfolio; 14.11.4 Recent Development 14.12 Hamilton Medical; 14.12.1 Company Snapshot; 14.12.2 Product Portfolio; 14.12.3 Recent Development; 14.13 Nice Neotech Medical Systems Pvt.Ltd.; 14.13.1 Company Snapshot; 14.13.2 Product Portfolio; 14.13.3 Recent Development; 14.14 Nipro; 14.14.1 Company Snapshot; 14.14.2 Revenue Analysis; 14.14.3 Product Portfolio; 14.14.4 Recent Development; 14.15 Pfizer Inc.; 14.15.1 Company Snapshot; 14.15.2 Revenue Analysis; 14.15.3 Product Portfolio; 14.15.4 Recent Development; 14.16 Resmed; 14.16.1 Company Snapshot; 14.16.2 Revenue Analysis; 14.16.3 Product Portfolio; 14.16.4 Recent Development; 14.17 Weinmann Emergency Medical Technology Gmbh + Co. Kg; 14.17.1 Company Snapshot; 14.17.2 Product Portfolio; 14.17.3 Recent Development
15 Questionnaire
16 Related Reports
List Of Tables: Table 1 List Of Prices For Approved Drugs For Acute Respiratory Distress Syndrome (Ards) Treatment; Table 2 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 3 Europe Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 4 Europe Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 5 Europe Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 6 Europe Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 7 Europe Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 8 Europe Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 9 Europe Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 10 Europe Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 11 Europe Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 12 Europe Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 13 Europe Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 14 Europe Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 15 Europe Extracorporeal Membrane Oxygenation (Ecmo) In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 16 Europe Tocilizumab In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 17 Europe Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 18 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 19 Europe Sepsis In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 20 Europe Inhalation Of Harmful Substances In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 21 Europe Severe Pneumonia In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 22 Europe Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 23 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 24 Europe Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 25 Europe Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 26 Europe Oral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 27 Europe Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 28 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 29 Europe Hospitals In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 30 Europe Specialty Clinics In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 31 Europe Home Healthcare In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 32 Europe Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 33 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 34 Europe Direct Tender In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 35 Europe Hospital Pharmacy In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 36 Europe Retail Pharmacy In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 37 Europe Online Pharmacy In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 38 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Country, 2021-2030 (Usd Thousand); Table 39 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 40 Europe Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 41 Europe Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 42 Europe Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 43 Europe Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 44 Europe Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 45 Europe Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 46 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 47 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 48 Europe Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 49 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 50 Europe Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 51 Germany Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 52 Germany Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 53 Germany Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 54 Germany Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 55 Germany Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 56 Germany Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 57 Germany Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 58 Germany Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 59 Germany Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 60 Germany Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 61 Germany Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 62 Germany Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 63 Germany Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 64 Germany Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 65 Germany Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 66 France Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 67 France Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 68 France Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 69 France Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 70 France Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 71 France Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 72 France Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 73 France Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 74 France Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 75 France Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 76 France Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 77 France Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 78 France Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 79 France Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 80 France Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 81 U.K. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 82 U.K. Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 83 U.K. Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 84 U.K. Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 85 U.K. Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 86 U.K. Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 87 U.K. Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 88 U.K. Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 89 U.K. Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 90 U.K. Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 91 U.K. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 92 U.K. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 93 U.K. Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 94 U.K. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 95 U.K. Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 96 Italy Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 97 Italy Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 98 Italy Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 99 Italy Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 100 Italy Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 101 Italy Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 102 Italy Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 103 Italy Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 104 Italy Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 105 Italy Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 106 Italy Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 107 Italy Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 108 Italy Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 109 Italy Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 110 Italy Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 111 Spain Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 112 Spain Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 113 Spain Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 114 Spain Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 115 Spain Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 116 Spain Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 117 Spain Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 118 Spain Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 119 Spain Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 120 Spain Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 121 Spain Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 122 Spain Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 123 Spain Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 124 Spain Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 125 Spain Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 126 Turkey Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 127 Turkey Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 128 Turkey Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 129 Turkey Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 130 Turkey Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 131 Turkey Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 132 Turkey Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 133 Turkey Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 134 Turkey Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 135 Turkey Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 136 Turkey Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand); Table 137 Turkey Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 138 Turkey Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 139 Turkey Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 140 Turkey Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 141 Netherlands Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 142 Netherlands Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 143 Netherlands Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 144 Netherlands Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 145 Netherlands Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 146 Netherlands Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume); Table 147 Netherlands Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp); Table 148 Netherlands Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 149 Netherlands Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)